Given that overexpression of vascular growth factor receptors are not likely to directly lead to increased angiogenesis in ATCs, mTOR signaling emerges as a key angiogenesis driving pathway in this cancer. Here, MTOR is linked to Ehlers-Danlos syndrome, musculocontractural type.